XACT Robotics is advancing the field of radiology, pioneering the first hands-free robotic system combining image-based planning.
XACT Robotics® is now a distinguished corporate member with goal of advancing interventional radiology.
XACT Robotics’ inclusion on the list is a testament to its innovation in technology, products and services – a category that highlights solutions with the potential to positively impact markets or the robotics sector as a whole.
Frost & Sullivan evaluated the North American percutaneous procedure system industry and based on its findings, recognized XACT Robotics with the 2021 North American Percutaneous Procedure System Technology Innovation Leadership Award.
Lahey Hospital & Medical Center (LHMC) and Sarasota Interventional Radiology (SIR) participated in trial to evaluate safety and accuracy of percutaneous procedures in the lung using the XACT ACE™ Robotic System for instrument insertion.
Lahey Hospital & Medical Center has acquired the XACT ACE™ Robotic System for use in its leading Interventional Radiology service.
XACT Robotics™ Ltd. today announced the successful completion of its latest financing round totaling $36 million.
XACT Robotics™ Ltd. today announced that its first robotic system was cleared to market in the U.S. for use during computed tomography (CT) guided percutaneous interventional procedures.
XACT Robotics Ltd. today announced that the European Patent Office (EPO) will grant a patent expanding the Company’s patent portfolio to include the use of its robotic system in ultrasound-guided interventional procedures.
Israel’s biotech and engineering sectors are aglow this month, in the wake of two big medical robotics buyouts of groundbreaking, homegrown technological solutions.
Medtronic is buying Prof. Moshe Shoham's Mazor for $1.6 billion, while he is looking forward to more robots and more startups.
XACT Robotics raised $5 million in venture capital investments alongside a new CE mark for its integrated robotic surgery navigation and steering system for image-guided, needle-puncture procedures, such as ablations and biopsies.
XACT Robotics out of Caesarea, Israel won EU approval to introduce its needle steering and insertion system for percutaneous procedures including biopsies and ablations.
Xact Robotics said today it won CE Mark approval in the European Union for its robotics navigation and steering system designed for image-guided percutaneous procedures, and said it raised $5 million in a Series C round of financing.
In the last few months, a Singaporean University hired Nadine as a secretary, a Boston Dynamics employee pushed over his colleague Atlas who was moving boxes at a factory and Tally, a San Francisco Target employee, began checking to make sure all the products in Aisle 3 are fully stocked.
The rapidly emerging field of robot-assisted surgery promises to revolutionize how doctors operate. Israel is one of the world leaders in this field.
The Israeli company will use the investment to fund US trials for its needle steering technology.
XACT Robotics is advancing the field of radiology, pioneering the first hands-free robotic system combining image-based planning and navigation with instrument insertion and steering capabilities, to democratize percutaneous interventional procedures.
XACT Robotics™ Ltd. today announced it will debut its first-to-market hands-free robotic technology at the Radiological Society of North America (RSNA) 2019 Annual Meeting in Chicago, IL on December 1 – 6, 2019.
XACT ACE™ Robotic System is the world’s first and only hands-free robotic system that combines advanced image-based procedure planning and navigation with robotic instrument insertion and non-linear steering capabilities.